(PharmaNewsWire.Com, July 21, 2020 ) The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations. However, factors such as limited reimbursement for dialysis in developing countries, high cost of dialysis treatment, lack of awareness about kidney diseases & treatment procedures among patients, and reuse of hemodialysis supplies are restraining the growth of this market. The evolution of new dialysis modalities, growth opportunities in emerging markets, increasing number of dialysis centers, and growing adoption of home dialysis treatment offer significant growth opportunities for players in the dialysis market.
The Asia and North Africa Hemodialysis & Peritoneal Dialysis market in emerging nations is projected to grow at a CAGR of 9.2% during the forecast period, and is expected to reach a value of USD 35.9 Billion by 2020.
The dialysis market in emerging nations is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis market is segmented into products and services.
Hemodialysis products include hemodialysis machines and hemodialysis consumables/supplies, whereas hemodialysis services are classified into in-center services and home services.
The peritoneal dialysis market, segmented into products and services, includes peritoneal dialysis machines, concentrates/dialysates, catheters, transfer sets, and other consumables such as tubing sets, drain bags, disconnect caps, bag connections, catheter stabilizing devices, and ports.
On the basis of region, the dialysis market in emerging nations is segmented into India, Asia (excluding India), and the MENA region. The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020). This high growth is predominantly driven by the growing number of dialysis centers, low preference for kidney transplantation, rising awareness about renal diseases, development of low-cost products, and increasing focus of dialysis firms on the Asian market.
The Indian dialysis market is expected to witness a lucrative CAGR during the forecast period due to the growing patient base, government focus on providing low-cost dialysis treatment and promoting the indigenous manufacturing of dialysis products, and the growing adoption of home dialysis treatment in the country.
The major players in the dialysis market in emerging nations include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), and Nikkiso Co. Ltd. (Japan).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
